EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a human-derived bioink based on keratin methacrylate for corneal bioprinting

Leon Balters, Stephan Reichl iD

Journal of Applied Biomaterials & Functional Materials · 2026-06 · 24

DOI: 10.1177/22808000261453778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Biomaterials & Functional Materials, online erschienen am 26.06.2026. Verfasst von Leon Balters und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Germany. Hauptthemen laut MEDLINE: Bioprinting, Keratins, Methacrylates, Cornea. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of suitable bioinks for bioprinting is still a key issue in the field of tissue engineering. Most of the biomaterials used are derived from animal sources. A novel bioink for corneal stroma bioprinting based on chemically modified keratin derived from human hair waste was developed and evaluated. To confirm the successful functionalization of methacrylated keratin (KerMA), various characterization methods such as 1 H-NMR, IR as well as a cytotoxity assay were performed. The newly developed biomaterial KerMA was mixed with methacrylated hyaluronic acid and bioprinted with cells as a corneal stroma substitute. Two different cell types were encapsulated in the bioink, immortalized corneal keratocytes and human corneal fibroblasts. The printed constructs were crosslinked under UV light and cultured for up to four weeks. The bioprinted constructs were monitored for four weeks for optical transparency, cell viability (live/dead staining), biomechanical properties and protein expression by indirect immunofluorescence. Furthermore, human corneal epithelial cells were seeded on top of the bioprinted constructs and demonstrated high cell viability. The bioprinted constructs showed good optical transparency and decent biomechanical properties. The addition of KerMA to methacrylated hyaluronic acid led to an improvement in cell viability and protein expression. This bioink approach offers a sustainable, ethically sourced alternative to animal-derived materials. It forms the basis for future in vitro and in vivo studies on the development of corneal tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprintingKeratinsMethacrylatesCorneaHumansCell SurvivalHyaluronic AcidTissue EngineeringFibroblastsTissue Scaffolds

Stichwörter der Autor:innen

bioprintingcorneahuman corneal fibroblastshyaluronic acidkeratin

Substanzen

KeratinsMethacrylatesHyaluronic Acid

Autor:innen und Institutionen

  • Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Germany.

ORCID-Profile: Stephan Reichl

Zitieren

APA

Balters, L., & Reichl, S. (2026). Development of a human-derived bioink based on keratin methacrylate for corneal bioprinting. Journal of Applied Biomaterials & Functional Materials, 24. https://doi.org/10.1177/22808000261453778

Vancouver

Balters L, Reichl S. Development of a human-derived bioink based on keratin methacrylate for corneal bioprinting. Journal of Applied Biomaterials & Functional Materials. 2026;24. doi:10.1177/22808000261453778

BibTeX
@article{Balters2026,
  author = {Balters, Leon and Reichl, Stephan},
  title = {Development of a human-derived bioink based on keratin methacrylate for corneal bioprinting},
  journal = {Journal of Applied Biomaterials & Functional Materials},
  year = {2026},
  volume = {24},
  doi = {10.1177/22808000261453778}
}
Kostenlos starten →